Mr William A Goodfellow, MD | |
1010 S. Batavia Ave., Geneva, IL 60134 | |
(630) 337-9490 | |
Not Available |
Full Name | Mr William A Goodfellow |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 1010 S. Batavia Ave., Geneva, Illinois |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770823585 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 036-042732 (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr William A Goodfellow, MD 1010 S. Batavia Ave., Geneva, IL 60134 Ph: (630) 337-9490 | Mr William A Goodfellow, MD 1010 S. Batavia Ave., Geneva, IL 60134 Ph: (630) 337-9490 |
News Archive
Heart attacks strike suddenly and have a range of different triggers. Researchers from Charité - Universitätsmedizin Berlin and the German Centre for Cardiovascular Research (DZHK) were able to uncover a further underlying cause.
Autoimmune diseases, in which the immune system attacks the body, are fairly common. Thyroid diseases, type 1 diabetes, rheumatoid arthritis, psoriasis and inflammatory bowel disease are some examples. Autoimmune diseases are associated with increased inflammation in the tissue, which in some cases is linked to an increased propensity to develop clots in the veins.
A newly published consensus report prepared by a panel of clinical experts, with sponsorship from Nestle Health Science, reveals that there are opportunities to do more to manage the impact of obesity on the delivery of critical care, particularly in the area of nutrition therapy.
The 2011 Sleep in America- poll released today by the National Sleep Foundation finds pervasive use of communications technology in the hour before bed. It also finds that a significant number of Americans aren't getting the sleep they say they need and are searching for ways to cope.
Aushon announced its plans today for an upcoming global launch of its new multiplex protein biomarker platform, which incorporates several engineering breakthroughs to deliver ELISA-level performance.
› Verified 4 days ago